35. Pemphigus Clinical trials / Disease details

Clinical trials : 98 / Drugs : 126 - (DrugBank : 41) / Drug target genes : 23 - Drug target pathways : 168

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04540133 (ClinicalTrials.gov)	December 26, 2020	28/8/2020	Dexamethasone Solution and Dexamethasone in Mucolox™	Dexamethasone Solution and Dexamethasone in Mucolox™ for the Treatment of Oral Inflammatory Ulcerative Diseases	Oral Lichen Planus;Mucous Membrane Pemphigoid;Pemphigus Vulgaris;Chronic Graft-versus-host-disease	Drug: dexamethasone 0.5mg/5ml solution;Drug: dexamethasone 0.5mg/5ml solution in Mucolox™	University of California, San Francisco	NULL	Recruiting	18 Years	N/A	All	30	Phase 2	United States
2	NCT00656656 (ClinicalTrials.gov)	January 2008	7/4/2008	Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus	Combined Treatment of Autoimmune Bullous Diseases With Protein A Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab	Pemphigus	Drug: Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine	University of Luebeck	NULL	Completed	18 Years	N/A	All	23	Phase 2	Germany
3	NCT00127764 (ClinicalTrials.gov)	January 2001	4/8/2005	European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus	European Randomised Placebo-Controlled Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus (Pempuls Trial)	Pemphigus	Drug: dexamethasone (50mg 1dd6, 3 consecutive days/month)	University Medical Centre Groningen	NULL	Completed	18 Years	N/A	Both	60	Phase 2/Phase 3	Netherlands